Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer’s Disease

被引:0
|
作者
Shwetha Nanjundaiah
Hariharakrishnan Chidambaram
Madhura Chandrashekar
Subashchandrabose Chinnathambi
机构
[1] CSIR-National Chemical Laboratory (CSIR-NCL),Neurobiology Group, Division of Biochemical Sciences
[2] Academy of Scientific and Innovative Research (AcSIR),School of Biomedical Engineering and Sciences
[3] MIT University,undefined
来源
关键词
Alzheimer’s disease; Amyloid-β protein; Tau hyperphosphorylation; Cholesterol; Microglia;
D O I
暂无
中图分类号
学科分类号
摘要
Cholesterol, a principal constituent of the cell membrane, plays a crucial role in the brain by regulating the synaptic transmission, neuronal signaling, as well as neurodegenerative diseases. Defects in the cholesterol trafficking are associated with enhanced generation of hyperphosphorylated Tau and Amyloid-β protein. Tau, a major microtubule-associated protein in the brain, is the key regulator of the mature neuron. Abnormally hyperphosphorylated Tau hampers the major functions related to microtubule assembly by promoting neurofibrillary tangles of paired helical filaments, twisted ribbons, and straight filaments. The observed pathological changes due to impaired cholesterol and Tau protein accumulation cause Alzheimer's disease. Thus, in order to regulate the pathogenesis of Alzheimer's disease, regulation of cholesterol metabolism, as well as Tau phosphorylation, is essential. The current review provides an overview of (1) cholesterol synthesis in the brain, neurons, astrocytes, and microglia; (2) the mechanism involved in modulating cholesterol concentration between the astrocytes and brain; (3) major mechanisms involved in the hyperphosphorylation of Tau and amyloid-β protein; and (4) microglial involvement in its regulation. Thus, the answering key questions will provide an in-depth information on microglia involvement in managing the pathogenesis of cholesterol-modulated hyperphosphorylated Tau protein.
引用
收藏
页码:651 / 668
页数:17
相关论文
共 50 条
  • [31] Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
    Shi-Dong Chen
    Jia-Ying Lu
    Hong-Qi Li
    Yu-Xiang Yang
    Jie-Hui Jiang
    Mei Cui
    Chuan-Tao Zuo
    Lan Tan
    Qiang Dong
    Jin-Tai Yu
    Translational Psychiatry, 11
  • [32] Staging tau pathology with tau PET in Alzheimer's disease: a longitudinal study
    Chen, Shi-Dong
    Lu, Jia-Ying
    Li, Hong-Qi
    Yang, Yu-Xiang
    Jiang, Jie-Hui
    Cui, Mei
    Zuo, Chuan-Tao
    Tan, Lan
    Dong, Qiang
    Yu, Jin-Tai
    TRANSLATIONAL PSYCHIATRY, 2021, 11 (01)
  • [33] Microglia and the immune pathology of Alzheimer disease
    Giulian, D
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (01) : 13 - 18
  • [34] The engagement of microglia in tau-targeted immunotherapy in Alzheimer's disease
    Palova, Denisa
    Csokova, Natalia Turic
    Markova, Karina
    Kontsekova, Eva
    Kovacech, Branislav
    Zilkova, Monika
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2021, 40 (06) : 463 - 478
  • [35] Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer's Disease
    Zhao, Yuanxin
    Liu, Buhan
    Wang, Jian
    Xu, Long
    Yu, Sihang
    Fu, Jiaying
    Yan, Xiaoyu
    Su, Jing
    BIOMEDICINES, 2022, 10 (08)
  • [36] The role of tau kinases in Alzheimer's disease
    Dolan, Philip J.
    Johnson, Gail V. W.
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2010, 13 (05) : 595 - 603
  • [37] Polygenic Effect on Tau Pathology Progression in Alzheimer's Disease
    Rubinski, Anna
    Frerich, Simon
    Malik, Rainer
    Franzmeier, Nicolai
    Ramirez, Alfredo
    Dichgans, Martin
    Ewers, Michael
    ANNALS OF NEUROLOGY, 2023, 93 (04) : 819 - 829
  • [38] Tau Mediated Neurodegeneration: An Insight into Alzheimer’s Disease Pathology
    M. Obulesu
    R. Venu
    R. Somashekhar
    Neurochemical Research, 2011, 36 : 1329 - 1335
  • [39] Biological mechanisms of resilience to tau pathology in Alzheimer's disease
    Svenningsson, Anna L.
    Bocancea, Diana I.
    Stomrud, Erik
    van Loenhoud, Anita
    Barkhof, Frederik
    Mattsson-Carlgren, Niklas
    Palmqvist, Sebastian
    Hansson, Oskar
    Ossenkoppele, Rik
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [40] CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease
    Hanna Rosenmann
    Journal of Molecular Neuroscience, 2012, 47 : 1 - 14